The Changing Role of a Histotechnologist

March 28, 2022

U.S. FDA reject anemia drug Evrenzo approved by UK’s NICE

June 14, 2022

BioMarin’s BMN 401 Meets One Primary Goal but Misses Clinical Endpoint in Late-Stage ENPP1 Deficiency Trial

May 20, 2026

Must Read

The Economics of Decentralized Clinical Trials

October 16, 2026

Top 10 AI Investments Delivering the Highest ROI in Pharma

October 16, 2026

Top 10 Drivers Behind Site-less Clinical Trials

October 15, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

BioNTech’s mRNA cancer vaccine fails phase 3 test

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Novartis agrees to pay Abogen $7.8 billion for its in vivo autoimmune T-cell engager

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

The Economics of Decentralized Clinical Trials

Top 10 AI Investments Delivering the Highest ROI in Pharma

Top 10 Drivers Behind Site-less Clinical Trials

Multi-Omics and the Next Generation of Drug Discovery

Insights

Vaccine Hesitancy on the Rise: Here’s Why Vaccine Clinical Trial Process Have Never Been Safer

Editor Picks

The Changing Role of a Histotechnologist

U.S. FDA reject anemia drug Evrenzo approved by UK’s NICE

BioMarin’s BMN 401 Meets One Primary Goal but Misses Clinical Endpoint in Late-Stage ENPP1 Deficiency Trial

Must Read

The Economics of Decentralized Clinical Trials

Top 10 AI Investments Delivering the Highest ROI in Pharma

Top 10 Drivers Behind Site-less Clinical Trials

Hot Topics

About Us

Follow Us